Which 2 Companies Are Paying Dividends This Week?

There are two companies which are paying dividends this week. These companies are Sapphire Corp Limited (SGX: BRD)(sgx analyst recommendation) and IHH Healthcare Bhd (SGX: Q0F). Sapphire Corp Limited (SGX: BRD) mainly deals in urban rail transport system, expressways, roads, bridges and among others. The Group owns a 100% stake in China-based Ranken Infrastructure Limited and its subsidiaries, which was founded in 1998 and it has since grown into one of the largest privately owned integrated rail transport infrastructure group in China. And IHH Healthcare Bhd (SGX: Q0F) (Singapore Stocks Signals) is the Group comprises premium-brand healthcare assets, collectively representing a unique multi-market investment position in the healthcare sector. Our "Mount Elizabeth", "Gleneagles", "Pantai", "Parkway" and "Acibadem" brands are among the most prestigious in Asia and Central and Eastern Europe. 

There are a couple of organizations going ex-profit in the following couple of days. As it were, you have to claim them before a specific date keeping in mind the end goal to get their profits. We should investigate two of them.(Stock tips) 

Tuesday, 26 June 2018 

On Tuesday, Sapphire Corp Limited (SGX: BRD) will go ex-profit. The organization is chiefly occupied by the urban rail and foundation building and development business. 

Sapphire Corp is doling out 0.1 Singapore penny for each offer for the final quarter. 

For the entire year finished 31 December 2017, income rose multi year-on-year to RMB 1.3 billion for the most part on the back of a higher number of continuous ventures in China. Be that as it may, net benefit slipped 5.1% to RMB 44.4 million principally because of higher different costs, back expenses and duty cost. 

The company's offers finished Friday at S$0.156, making an interpretation of to a cost-to-income (PE) proportion of 6 and a profit yield of 0.6%. 

Wednesday, 27 June 2018 

IHH Healthcare Bhd (SGX: Q0F) is penciled in to go ex-profit on Wednesday. The firm is a supplier of premium coordinated medicinal services benefits in Malaysia, Singapore, Turkey, and India. 

IHH is giving out 3.0 Malaysia sen for each offer for the final quarter. 

Income for the entire year finished 31 December 2017 grew multi year-on-year to RM 11.1 billion while net benefit surged 58% to RM 970.0 million. 

The expansion in the best line was because of natural development from the current tasks, and additionally proceeded with an increase of the doctor's facilities opened amid the year. Bulgaria's Tokuda and City Clinic Group likewise added to the higher income after their acquisitions in June 2016. (stock tips)

The overseeing chief of IHH, Dr. Tan See Leng, stated: 

"In 2017, we improved the nature of our arrangement of center resources while situating for development. Our current healing facilities keep on performing, Gleneagles Hong Kong and Acibadem Altunizade are increased, and we put resources into key resources including diagnostics player Angsana Holdings, to additionally separate our administration contributions. Proactive administration of our capital structure and the monetary record has put us in a strong position to develop; this incorporates staging our activities dynamically to oversee costs, discarding non-center resources and setting up a US$2 billion multi-money medium-term note program. 

Looking forward, we are balanced for development. Our more current healing centers will wind up distinct advantages for the Group, with Gleneagles Hong Kong specifically, putting us well while in transit to making Greater China our fifth home market as our slate of clinic ventures comes to fruition." 

On Friday, IHH shut at S$2.02 per share, giving a PE proportion of somewhat under 100 and a profit yield of 0.5%.(stock research singapore)

Worried about the overall state of the market? Do you know the 1 thing you should never do in the stock market? The plan to handle market crashes details the greatest advantage you have as an investor and looks at decades worth of market data to bring you the smartest insights on investing. source